Arch Therapeutics, Inc. (ARTH) News https://ir.archtherapeutics.com/section-16-filings/rss Arch Therapeutics, Inc. (ARTH) - Section 16 Filings en-us Equisolve Investor Relations Suite http://content.stockpr.com/archtherapeutics/files/images/logo-header.png https://www.archtherapeutics.com <![CDATA[ 15-12G - Securities registration termination [Section 12(g)] ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11866-0001537561-26-000002 Mon, 12 Jan 26 06:01:53 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11866-0001537561-26-000002 <![CDATA[ 8-K - Current report ]]> 8-K, EX-16.1 ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11865-0001641172-25-012288 Fri, 23 May 25 16:31:03 -0400 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11865-0001641172-25-012288 <![CDATA[ RW - Registration Withdrawal Request ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11863-0001641172-25-012268 Fri, 23 May 25 16:15:39 -0400 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11863-0001641172-25-012268 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11862-0001493152-25-005383 Fri, 07 Feb 25 16:00:45 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11862-0001493152-25-005383 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11861-0001493152-25-003400 Thu, 23 Jan 25 16:31:24 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11861-0001493152-25-003400 <![CDATA[ NT 10-K - Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11860-0001493152-24-052705 Tue, 31 Dec 24 16:18:00 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11860-0001493152-24-052705 <![CDATA[ SC 13G/A - Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11859-0000921895-24-002635 Wed, 13 Nov 24 17:26:16 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11859-0000921895-24-002635 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11858-0001493152-24-044026 Thu, 07 Nov 24 16:45:18 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11858-0001493152-24-044026 <![CDATA[ 8-K - Current report filing ]]> 8-K, EX-10.1, EX-10.2, EX-10.3, EX-10.4, EX-10.5 ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11857-0001493152-24-043518 Mon, 04 Nov 24 16:31:44 -0500 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11857-0001493152-24-043518 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=1#document-11851-0001493152-24-038340 Thu, 26 Sep 24 17:00:40 -0400 https://ir.archtherapeutics.com/section-16-filings?page=1#document-11851-0001493152-24-038340 <![CDATA[ 8-K - Current report filing ]]> 8-K, EX-10.1, EX-10.2, EX-10.3, EX-10.4, EX-10.5, EX-10.6 ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11850-0001493152-24-037130 Thu, 19 Sep 24 16:31:19 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11850-0001493152-24-037130 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11843-0001493152-24-036208 Fri, 13 Sep 24 16:31:25 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11843-0001493152-24-036208 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11842-0001493152-24-034600 Fri, 30 Aug 24 16:31:14 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11842-0001493152-24-034600 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11841-0001493152-24-033295 Tue, 20 Aug 24 17:20:08 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11841-0001493152-24-033295 <![CDATA[ 10-Q - Quarterly report pursuant to Section 13 or 15(d) ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1 ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11840-0001493152-24-033091 Mon, 19 Aug 24 16:37:54 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11840-0001493152-24-033091 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11830-0001493152-24-032873 Fri, 16 Aug 24 17:17:31 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11830-0001493152-24-032873 <![CDATA[ 8-K - Current report filing ]]> 8-K, EX-10.1, EX-10.2, EX-10.3, EX-10.4, EX-10.5 ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11836-0001493152-24-032876 Fri, 16 Aug 24 17:17:43 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11836-0001493152-24-032876 <![CDATA[ NT 10-Q - Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11829-0001493152-24-032353 Wed, 14 Aug 24 17:00:59 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11829-0001493152-24-032353 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11828-0001493152-24-030082 Fri, 02 Aug 24 16:16:06 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11828-0001493152-24-030082 <![CDATA[ 8-K - Current report filing ]]> https://ir.archtherapeutics.com/section-16-filings?page=2#document-11827-0001493152-24-028684 Mon, 22 Jul 24 16:06:59 -0400 https://ir.archtherapeutics.com/section-16-filings?page=2#document-11827-0001493152-24-028684